Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikhail Dozmorov

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Glycobiology|August 1, 2013
Fucosyltransferase VII improves the function of selectin ligands on cord blood hematopoietic stem cellsXiang Wan, Hidetaka Sato, Hiromasa Miyaji, et al.
Breast Cancer Research and Treatment|July 22, 2019
Syndecan-1 facilitates breast cancer metastasis to the brainMegan R Sayyad, Madhavi Puchalapalli, Natasha G Vergara, et al.
Alcoholism, Clinical and Experimental Research|October 17, 2020
Assessing the Role of Long Noncoding RNA in Nucleus Accumbens in Subjects With Alcohol DependenceJohn Drake, Gowon O McMichael, Eric Sean Vornholt, et al.
Cell Reports|March 2, 2022
Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinomaFaridoddin Mirshahi, Hussein F Aqbi, Madison Isbell, et al.
Science Translational Medicine|May 18, 2018
Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastomaTimothy L Lochmann, Krista M Powell, Jungoh Ham, et al.
Communications Biology|April 11, 2026
Orientia tsutsugamushi targets lamin A using Ank effectors and alters chromatin to inhibit NF-κBThomas E Siff, Paige E Allen, Haley E Adcox, et al.
Cell Reports|July 29, 2022
High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibitionJinyang Cai, Sheeba Jacob, Richard Kurupi, et al.
Molecular Cancer Therapeutics|June 5, 2021
Venetoclax-based Rational Combinations are Effective in Models of <i>MYCN</i>-amplified NeuroblastomaKrista M Dalton, Kateryna Krytska, Timothy L Lochmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2021
Catastrophic ATP loss underlies a metabolic combination therapy tailored for <i>MYCN</i>-amplified neuroblastomaKrista M Dalton, Timothy L Lochmann, Konstantinos V Floros, et al.
Hepatology (Baltimore, Md.)|April 25, 2017
A novel role of astrocyte elevated gene-1 (AEG-1) in regulating nonalcoholic steatohepatitis (NASH)Jyoti Srivastava, Chadia L Robertson, Kareem Ebeid, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Glycobiology|August 1, 2013
Fucosyltransferase VII improves the function of selectin ligands on cord blood hematopoietic stem cellsXiang Wan, Hidetaka Sato, Hiromasa Miyaji, et al.
Breast Cancer Research and Treatment|July 22, 2019
Syndecan-1 facilitates breast cancer metastasis to the brainMegan R Sayyad, Madhavi Puchalapalli, Natasha G Vergara, et al.
Alcoholism, Clinical and Experimental Research|October 17, 2020
Assessing the Role of Long Noncoding RNA in Nucleus Accumbens in Subjects With Alcohol DependenceJohn Drake, Gowon O McMichael, Eric Sean Vornholt, et al.
Cell Reports|March 2, 2022
Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinomaFaridoddin Mirshahi, Hussein F Aqbi, Madison Isbell, et al.
Science Translational Medicine|May 18, 2018
Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastomaTimothy L Lochmann, Krista M Powell, Jungoh Ham, et al.
Communications Biology|April 11, 2026
Orientia tsutsugamushi targets lamin A using Ank effectors and alters chromatin to inhibit NF-κBThomas E Siff, Paige E Allen, Haley E Adcox, et al.
Cell Reports|July 29, 2022
High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibitionJinyang Cai, Sheeba Jacob, Richard Kurupi, et al.
Molecular Cancer Therapeutics|June 5, 2021
Venetoclax-based Rational Combinations are Effective in Models of <i>MYCN</i>-amplified NeuroblastomaKrista M Dalton, Kateryna Krytska, Timothy L Lochmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2021
Catastrophic ATP loss underlies a metabolic combination therapy tailored for <i>MYCN</i>-amplified neuroblastomaKrista M Dalton, Timothy L Lochmann, Konstantinos V Floros, et al.
Hepatology (Baltimore, Md.)|April 25, 2017
A novel role of astrocyte elevated gene-1 (AEG-1) in regulating nonalcoholic steatohepatitis (NASH)Jyoti Srivastava, Chadia L Robertson, Kareem Ebeid, et al.
Pageof 5